New data suggest that proton therapy may be associated with a higher rate of gastrointestinal problems and may not produce better outcomes than IMRT in men with localized prostate cancer. Yet, proton therapy is growing in popularity. John Schieszer has the latest on the story in today’s Medical Minute.